Know More About “Fertility Supplements Market 2024-2030” Growth Worldwide…..|Grand View Research, Inc.

Written by

San Francisco, 02 April 2024: The Report Fertility Supplements Market Size, Share & Trends Analysis Report By Ingredient Type, Product Type, By End-user, By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2030

The global fertility supplements market is expected to reach USD 3.52 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.1% during the forecast period and is driven by factors such as rising healthcare costs, changing lifestyles, and medical advancements. Furthermore, the rising trend of women delaying pregnancies and rising concerns over the ongoing decline in fertility rates will boost market growth.

Synthetic/blend of natural and synthetic fertility supplements accounted for the largest market share. These supplements contain a mix of vitamins and natural ingredients to assist in boosting fertility. Selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and Myo-Inositol are among the major synthetic ingredients that are in demand and are easily available.

The capsules, tablets, and soft gels were the prominent product segments in the market. Capsules held a major share in 2022 owing to microencapsulation in the health and wellness industry. It ensures the controlled release and quick absorption of finished products and helps protect sensitive compounds such as polyphenols or probiotics. This is expected to prompt manufacturers to opt for capsule dosage forms over the forecast period. However, high prices incurred during the blistering packaging method are projected to refrain manufacturers from using capsule formulation over the forecast period.

Tablets are highly used because of their cost-effectiveness. Quality tablets and supplements largely use excipients which assist in quicker absorption and disintegration of tablets. Moreover, the natural coating provides better dissolution, while there are some other factors that determine the absorption based on efficacy and quality. All these factors are expected to drive the demand for tablet-type fertility supplements in the forecast period.

The use of plant-derived products has risen globally due to the increasing vegan population and emphasis on reducing the risk of side effects when consuming supplements. This trend will bode well for natural fertility supplements over the forecast period. According to an article published by the World Health Organization in May 2023, approximately 40% of the pharmaceutical products today are drawn from nature and traditional knowledge.

The market is driven by factors such as rising healthcare costs, changing lifestyles, and medical advancements. Furthermore, the rising trend of women delaying pregnancies and increasing concerns over the ongoing decline in fertility rates will boost market growth.

Request sample report of Fertility Supplements Market@ https://www.grandviewresearch.com/industry-analysis/fertility-supplements-market/request/rs1

Various lifestyle habits such as smoking, alcohol consumption, poor diet, and mental stress are attributable to increasing infertility. Women experiencing a more significant amount of stress are more likely to produce high levels of alpha-amylase and, in turn, face difficulty in getting pregnant. These factors are expected to increase the infertility rate globally over the forecast period, thereby increasing the demand for fertility supplements.

Fertility Supplements Market Report Highlights

  • Synthetic/Blend of Natural and synthetic fertility supplements dominated the market, having accounted for a revenue share of 89.1% in 2023.These supplements contain a mix of vitamins and natural ingredients to assist in boosting fertility. Selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and Myo-Inositol are among the major synthetic ingredients that are in demand and are easily available.
  • Capsule-based fertility supplements dominated the market, having accounted for a revenue share of 39.9% in 2023. Capsules offer consumers a convenient and precise way to deliver a consistent dose of ingredients. Furthermore, capsules eliminate the need for measuring and mixing, saving time and simplifying the consumption process. Hence, capsules will continue to remain the dominant product type in the fertility supplements market during the forecast period.
  • North America dominated the market for fertility supplements and accounted for a 35.6% share of the global revenue in 2023. Due to the rising rate of infertility and increased public awareness of general health, North America is predicted to experience significant growth over the forecast period.

The World Health Organization claims that several factors, including rising rates of smoking and alcohol use, an increase in the obese population, and elevated stress levels leading to hormonal imbalances, are responsible for the widespread issue of infertility. Factors contributing to infertility include age, gaining weight, polycystic ovarian syndrome (PCOS), or repeated miscarriages, which consequently affect their families and the community.

According to OECD data released in 2023, Korea, France, Sweden, and Switzerland’s total fertility rates (TFR) in 2021 were 0.81, 1.80, 1.67, and 1.51, respectively, lower than the average TFR of 2.1. Over one in four adults is obese in Chile, Australia, South Africa, Canada, and the UK. Over the past decade, the prevalence of obesity has increased in Switzerland, France, the U.S., Canada, and Mexico; on the contrary, it has stabilized in Spain, Italy, England, and Korea.

Various lifestyle habits such as smoking, alcohol consumption, poor diet, and mental stress are attributable to increasing infertility. Women experiencing a more significant amount of stress are more likely to produce high levels of alpha-amylase and, in turn, face difficulty in getting pregnant. All these factors are expected to increase the infertility rate globally over the forecast period, thereby increasing the demand for fertility supplements.

Fertility Supplements Market Report Scope

Report Attribute Details
Market size value in 2024 USD 2.20 billion
Revenue forecast in 2030 USD 3.52 billion
Growth rate CAGR of 8.1% from 2024 to 2030
Base year for estimation 2023
Historical data 2017 – 2022
Forecast period 2024 – 2030

Key Fertility Supplements Company Insights

Fairhaven Health; Active Bio Life Science GmbH; LENUS Pharma GesmbH; and Coast Science are some of the dominant players operating in the fertility supplements market.

  • Coast Science the company is recommended across the globe by over 1400 physicians in 49 countries. The company is an affiliated member and copartner of the European Society for Human Reproduction, Endocrinology, the American Society for Reproductive Medicine, the American Urological Association, the Middle Eastern Fertility Society, and the Canadian Fertility and Andrology Society.
  • Fairhaven Health is a designer, manufacturer, and supplier of products for promoting male and female fertility, breastfeeding, and pregnancy wellness. It also offers natural fertility products to help conceive. The company’s fertility supplements products also aim to promote reproductive health in women and men; ovulation predictors, such as fertile focus ovulation microscopes, OvaCue fertility monitors; basal thermometers, ovulation tests; prenatal vitamins, BFP pregnancy, and breastfeeding support products.

Crown Nutraceuticals (Crown Fertility); extreme V, Inc.; and Babystart are some of the emerging market players functioning in fertility supplements market.

  • RBK Nutraceuticals Pty Ltd. specializes in dietary supplement products and focuses on bringing natural products manufactured at a pharmaceutical grade quality standard affordably. Various products manufactured by the company are Gluzin- Zinc Gluconate, Citrumelon- Citrulline, Citruaid- Citrulline, Heartflo- CoQ10, Toco VE- Vitamin E, and Heartflo Plus- CoQ10 + VE.

List of Key Players in the Fertility Supplements Market

  • Fairhaven Health
  • Coast Science
  • Lenus Pharma GesmbH
  • Active Bio Life Science GmbH
  • Orthomol
  • Exeltis USA, Inc.
  • Bionova
  • Fertility Nutraceuticals LLC
  • Vitabiotics Ltd.
  • extreme V, Inc.
  • Xena Bio Herbals Pvt. Ltd.

 

Article Categories:
News

Leave a Reply

Your email address will not be published. Required fields are marked *